Clinical Trial Update: Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating short-term dual antiplatelet therapy with an early transition to low-dose antiplatelet monotherapy using ticagrelor in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Messina | Conditions: Chronic Coronary Syndrome | Phase 4 | Status: NOT_YET_RECRUITING